Literature DB >> 24895414

Risk prediction models for melanoma: a systematic review.

Juliet A Usher-Smith1, Jon Emery2, Angelos P Kassianos3, Fiona M Walter2.   

Abstract

Melanoma incidence is increasing rapidly worldwide among white-skinned populations. Earlier diagnosis is the principal factor that can improve prognosis. Defining high-risk populations using risk prediction models may help targeted screening and early detection approaches. In this systematic review, we searched Medline, EMBASE, and the Cochrane Library for primary research studies reporting or validating models to predict risk of developing cutaneous melanoma. A total of 4,141 articles were identified from the literature search and six through citation searching. Twenty-five risk models were included. Between them, the models considered 144 possible risk factors, including 18 measures of number of nevi and 26 of sun/UV exposure. Those most frequently included in final risk models were number of nevi, presence of freckles, history of sunburn, hair color, and skin color. Despite the different factors included and different cutoff values for sensitivity and specificity, almost all models yielded sensitivities and specificities that fit along a summary ROC with area under the ROC (AUROC) of 0.755, suggesting that most models had similar discrimination. Only two models have been validated in separate populations and both also showed good discrimination with AUROC values of 0.79 (0.70-0.86) and 0.70 (0.64-0.77). Further research should focus on validating existing models rather than developing new ones. ©2014 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2014        PMID: 24895414     DOI: 10.1158/1055-9965.EPI-14-0295

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  32 in total

1.  A Randomized Trial on the Efficacy of Mastery Learning for Primary Care Provider Melanoma Opportunistic Screening Skills and Practice.

Authors:  June K Robinson; Namita Jain; Ashfaq A Marghoob; William McGaghie; Michael MacLean; Pedram Gerami; Brittney Hultgren; Rob Turrisi; Kimberly Mallett; Gary J Martin
Journal:  J Gen Intern Med       Date:  2018-02-05       Impact factor: 5.128

2.  Nevus count associations with pigmentary phenotype, histopathological melanoma characteristics and survival from melanoma.

Authors:  Nicholas J Taylor; Nancy E Thomas; Hoda Anton-Culver; Bruce K Armstrong; Colin B Begg; Klaus J Busam; Anne E Cust; Terence Dwyer; Lynn From; Richard P Gallagher; Stephen B Gruber; Diane E Nishri; Irene Orlow; Stefano Rosso; Alison J Venn; Roberto Zanetti; Marianne Berwick; Peter A Kanetsky
Journal:  Int J Cancer       Date:  2016-05-30       Impact factor: 7.396

Review 3.  Epidemiological and genetic factors underlying melanoma development in Italy.

Authors:  Giuseppe Palmieri; Maria Colombino; Milena Casula; Mario Budroni; Antonella Manca; Maria Cristina Sini; Amelia Lissia; Ignazio Stanganelli; Paolo A Ascierto; Antonio Cossu
Journal:  Melanoma Manag       Date:  2015-05-18

Review 4.  Genome-wide association studies and polygenic risk scores for skin cancer: clinically useful yet?

Authors:  M R Roberts; M M Asgari; A E Toland
Journal:  Br J Dermatol       Date:  2019-07-07       Impact factor: 9.302

5.  Independent validation of six melanoma risk prediction models.

Authors:  Catherine M Olsen; Rachel E Neale; Adèle C Green; Penelope M Webb; David C Whiteman
Journal:  J Invest Dermatol       Date:  2014-12-30       Impact factor: 8.551

6.  Novel GHRH antagonists suppress the growth of human malignant melanoma by restoring nuclear p27 function.

Authors:  Luca Szalontay; Andrew V Schally; Petra Popovics; Irving Vidaurre; Awtar Krishan; Marta Zarandi; Ren-Zhi Cai; Anna Klukovits; Norman L Block; Ferenc G Rick
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

7.  Development and Validation of Lifestyle-Based Models to Predict Incidence of the Most Common Potentially Preventable Cancers.

Authors:  Juliet A Usher-Smith; Stephen J Sharp; Robert Luben; Simon J Griffin
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2018-09-13       Impact factor: 4.254

Review 8.  Risk Prediction Models for Colorectal Cancer: A Systematic Review.

Authors:  Juliet A Usher-Smith; Fiona M Walter; Jon D Emery; Aung K Win; Simon J Griffin
Journal:  Cancer Prev Res (Phila)       Date:  2015-10-13

Review 9.  Recent Advances in Nanotechnology for the Treatment of Melanoma.

Authors:  Roberta Cassano; Massimo Cuconato; Gabriella Calviello; Simona Serini; Sonia Trombino
Journal:  Molecules       Date:  2021-02-03       Impact factor: 4.411

10.  Genomic Risk Score for Melanoma in a Prospective Study of Older Individuals.

Authors:  Andrew Bakshi; Mabel Yan; Moeen Riaz; Galina Polekhina; Suzanne G Orchard; Jane Tiller; Rory Wolfe; Amit Joshi; Yin Cao; Aideen M McInerney-Leo; Tatiane Yanes; Monika Janda; H Peter Soyer; Anne E Cust; Matthew H Law; Peter Gibbs; Catriona McLean; Andrew T Chan; John J McNeil; Victoria J Mar; Paul Lacaze
Journal:  J Natl Cancer Inst       Date:  2021-10-01       Impact factor: 11.816

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.